EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

De Novo Discovery of Nonstandard Thioisoindole‐Bridged Bicyclic Peptides Targeting Traf2‐ and NCK‐Interacting Kinase

Yue Zhang iD, Alexander A Vinogradov iD, Keisuke Hamada iD, Yin Sun, Toru Sengoku iD, Hiroaki Suga iD

Angewandte Chemie International Edition · 05.10.2026 · 65 (41)

DOI: 10.1002/anie.2417165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 13.08.2026. Verfasst von Yue Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, TNF Receptor-Associated Factor 2, Indoles, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Specially Promoted Research, Japan Society for the Promotion of Science, NUS Presidential Young Professor program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrocyclization strategies that generate conformationally constrained peptide scaffolds within nucleotide‐encoded library screening platforms have significantly advanced the discovery of de novo bioactive peptides. We previously reported ribosomal synthesis of topologically defined thioisoindole‐bridged bicyclic (TiB) peptides, but complete conversion required overnight incubation. Here, we reengineer the key ribosomally incorporated substrate to accelerate TiB formation to full conversion within 2 h. This was followed by a streptavidin‐based pulldown step to efficiently remove linear species and purify the desired TiB peptides. The optimized chemistry was incorporated into the RaPID (Random nonstandard peptides integrated discovery) system to enable de novo identification of TiB peptide ligands. As a proof of concept, two complementary TiB libraries were screened against Traf2‐ and NCK‐interacting kinase (TNIK). Of the five TiB candidates identified, four exhibited nanomolar affinity for TNIK (best K D = 12.3 nM), and the most potent ligand, TK7, inhibited TNIK kinase activity with an IC 50 of 60 nM. X‐ray crystallography revealed that TK7 adopts a unique binding mode on the TNIK surface. Collectively, these findings establish a practical platform for TiB peptide discovery, highlighting their potential in early‐stage peptide drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesTNF Receptor-Associated Factor 2IndolesPeptidesProtein Kinase InhibitorsPeptides, CyclicHumans

Stichwörter der Autor:innen

Peptide drug discoveryRaPID systemmRNA display

Substanzen

Protein Serine-Threonine KinasesTNF Receptor-Associated Factor 2TNIK protein, humanIndolesPeptidesProtein Kinase InhibitorsPeptides, Cyclic

Autor:innen und Institutionen

  • Department of Chemistry, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Department of Pharmaceutical and Artificial-Intelligence Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore.
  • Department of Biochemistry, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

ORCID-Profile: Yue Zhang, Alexander A Vinogradov, Keisuke Hamada, Toru Sengoku, Hiroaki Suga

Förderung

  • Specially Promoted Research
  • Japan Society for the Promotion of Science
  • NUS Presidential Young Professor program
  • NSFC Young Scientists Fund
  • Basis for Supporting Innovative Drug Discovery and Life Science Research

Zitieren

APA

Zhang, Y., Vinogradov, A. A., Hamada, K., Sun, Y., Sengoku, T., & Suga, H. (2026). De Novo Discovery of Nonstandard Thioisoindole‐Bridged Bicyclic Peptides Targeting Traf2‐ and NCK‐Interacting Kinase. Angewandte Chemie International Edition, 65(41). https://doi.org/10.1002/anie.2417165

Vancouver

Zhang Y, Vinogradov AA, Hamada K, Sun Y, Sengoku T, Suga H. De Novo Discovery of Nonstandard Thioisoindole‐Bridged Bicyclic Peptides Targeting Traf2‐ and NCK‐Interacting Kinase. Angewandte Chemie International Edition. 2026;65(41). doi:10.1002/anie.2417165

BibTeX
@article{Zhang2026,
  author = {Zhang, Yue and Vinogradov, Alexander A and Hamada, Keisuke and Sun, Yin and Sengoku, Toru and Suga, Hiroaki},
  title = {De Novo Discovery of Nonstandard Thioisoindole‐Bridged Bicyclic Peptides Targeting Traf2‐ and NCK‐Interacting Kinase},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {41},
  doi = {10.1002/anie.2417165}
}
Kostenlos starten →